We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · May 14, 2022

Ramucirumab in Patients With Advanced Biliary Tract Cancer Previously Treated With Gemcitabine-Based Chemotherapy

Clinical Cancer Research

 

Additional Info

Clinical Cancer Research
Phase II Study of Ramucirumab in Advanced Biliary Tract Cancer Previously Treated by Gemcitabine-based Chemotherapy
Clin. Cancer Res 2022 Mar 21;[EPub Ahead of Print], S Lee, RT Shroff, S Makawita, L Xiao, A Danner De Armas, P Bhosale, K Reddy, A Shalaby, K Raghav, S Pant, RA Wolff, M Javle

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading